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Reply
Our answer to the Letter entitled ‘‘Superantigens in T cell mediated
skin diseases – more than a coincidence!’’ is rather simple and goes
back to criteria established already by Robert Koch for the
attribution of a particular disease to a particular microbial pathogen.
Staphylococcus aureus was not detected in 37% of the study group
and therefore this microorganism could not account for atopic
dermatitis in these patients (Jappe et al, 1998). Furthermore, only
45% of the S. aureus isolates from the 63% of the study group
carrying this microorganism on their skin had the genotype for the
In Vitro Determination of Erythema and Immunologic
Protection Afforded by Sunscreens do not Accord with In Vivo
Assessments
To the Editor:
As members of the cosmetic industry involved in sunscreen research
and development, and currently working on photoimmunologic
protection afforded by sunscreens, we would like to add our
comments to those from Gasparro (1998) and Wolf and Kripke
(1998) on Davenport et al’s publication (1997), particularly after
reading Chu et al’s (1998) responses to these comments.
The statement ‘‘sunscreens protect against immunosuppression
beyond their designated sun protection factor (SPF)’’ is incorrect.
Re-analysis of the data shows exactly the opposite. In addition, we
want to state that SPF determined in vitro by the Diffey method
often do not correlate with the in vivo SPF (Diffey and Farr, 1991).
For example, based on our extensive experience, sunscreen A (2%
octyl-methoxy cinnamate) would be expected to have an in vivo
SPF around 2 (5.7 found in vitro), sunscreen B (2% o-PABA) a SPF
of 2.5 (4.5 found in vitro), and sunscreen E (6% ZnO) a SPF of 5
(3.8 found in vitro). So, the conclusion that cream A, which
provided the highest immune protection, is the cream that had the
highest in vitro SPF is valid only for an in vitro situation and this
model of evaluation.
We also disagree with one of the other conclusions of this work:
‘‘Protection by creams D and E, broad-spectrum sunscreens, is
lower than protection afforded by pure UVB sunscreens (creams
A and B).’’ Indeed, the published in vivo results issued from our
laboratory and from other international teams have demonstrated
just the opposite: sunscreens containing both UVA and UVB filters
are more effective against photoimmunosuppression than pure
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superantigens analyzed. This would clearly indicate that these
superantigens were not involved in the pathology. The design of
the investigation does allow the hypothesis of cause and effect, S.
aureus and atopic dermatitis, to be tested. Assuming that genetic
disposition of the individual is essential combined with an extraneous
environmental factor, in this case S. aureus superantigen producer,
then atopic dermatitis would occur only when S. aureus was present
on the skin. The hypothesis that S. aureus skin colonization is a
prerequisite for atopic dermatitis is greatly weakened by our
data. This investigation strengthens the hypothesis that other
environmental factors, apart from S. aureus, are important in atopic
dermatitis.
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UVB formulations (Bestak et al. 1995; Damian et al. 1997, Serre
et al. 1997, Gueniche and Fourtanier, 1997; Moyal, 1998). We
have also demonstrated that the higher the UVA protection level,
the better the immune system is protected, and that sunscreen
protection factor against immunosuppression are lower than their
in vivo SPF.
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